Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Eriksson%2C+Carl%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Eriksson%2C+Carl%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease : results from nationwide Swedish registers
Rundquist, Sara ; Sachs, Michael C. ; Eriksson, Carl ; Olén, Ola ; Montgomery, Scott and Halfvarson, Jonas (2021) In Alimentary Pharmacology and Therapeutics 53(4). p.471-483
- Contribution to journal › Article
Mark Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Eriksson, Carl ; Visuri, Isabella ; Vigren, Lina ^LU ; Nilsson, Linda ^LU ; Kärnell, Anders ; Hjortswang, Henrik ; Bergemalm, Daniel ; Almer, Sven ^LU ; Hertervig, Erik ^LU and Karlén, Per , et al. (2021) In Scandinavian Journal of Gastroenterology 56(11). p.1304-1311
- Contribution to journal › Article
Mark Predictors of drug survival : A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
Visuri, Isabella ; Eriksson, Carl ; Olén, Ola ; Cao, Yang ; Mårdberg, Emelie ; Grip, Olof ^LU ; Gustavsson, Anders ; Hjortswang, Henrik ; Karling, Pontus and Montgomery, Scott , et al. (2021) In Alimentary Pharmacology and Therapeutics 54(7). p.931-943
- Contribution to journal › Article
Mark Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
Eriksson, Carl ; Rundquist, Sara ; Lykiardopoulos, Vyron ; Udumyan, Ruzan ; Karlén, Per ; Grip, Olof ^LU ; Söderman, Charlotte ; Almer, Sven ; Hertervig, Erik and Marsal, Jan ^LU , et al. (2021) In Therapeutic Advances in Gastroenterology 14.
- Contribution to journal › Article
2020
Mark The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
Shrestha, Sarita ; Olén, Ola ; Eriksson, Carl ; Everhov, Åsa H ; Myrelid, Pär ; Visuri, Isabella ; Ludvigsson, Jonas F ; Schoultz, Ida ; Montgomery, Scott and Sachs, Michael C , et al. (2020) In Scandinavian Journal of Gastroenterology 55(4). p.430-435
- Contribution to journal › Article
2018
Mark Clinical effectiveness of golimumab in Crohn’s disease : an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Rundquist, Sara ; Eriksson, Carl ; Nilsson, Linda ; Angelison, Leif ^LU ; Jäghult, Susanna ; Björk, Jan ; Grip, Olof ^LU ; Hjortswang, Henrik ; Strid, Hans and Karlén, Per , et al. (2018) In Scandinavian Journal of Gastroenterology 53(44845). p.1257-1263
- Contribution to journal › Article
2017
Mark Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Eriksson, Carl ; Marsal, Jan ^LU ; Bergemalm, Daniel ; Vigren, Lina ^LU ; Björk, Jan ; Eberhardson, Michael ; Karling, Pontus ; Söderman, Charlotte ; Myrelid, Pär and Cao, Yang , et al. (2017) In Scandinavian Journal of Gastroenterology 52(6-7). p.722-729
- Contribution to journal › Article